SIGMA Healthcare Limited emerged as a focal point in last Fri's ASX announcement by S&P Dow Jones Indices, regarding changes coming to the S&P/ASX 200 index.
With Boral Limited preparing to exit due to an off-market takeover offer from Seven Group Holdings Limited, Sigma Healthcare Limited has stepped up into the spotlight.
Effective before the market opens on Fri 10 May, Boral Limited will relinquish its position in the index, paving the way for Sigma Healthcare Limited to assume its role.
The ASX statement regarding the inclusion of Sigma Healthcare Limited in the S&P/ASX 200 index underscores its growing significance in the Australian market.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 May 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 May 24
